Total amount of monetary losses as a result of legal proceedings associated with controlled substances

Unit

i
: Currency

Indicator

i
: Business exposure to nature risks and opportunities

Metric type

i
: Other

Framework alignment notes

i
HC-DR-260a.2
Refer to AMR's Shared Goals for alignment to metric
T15

Target example

[Company name] will maintain zero financial losses related to legal proceedings associated with [list controlled substances] annually

Target Source: WBCSD target template

Sector

i
Pharmaceutical

Value chain stage

i
Manufacturing End of Life

Metric assessment

i

Relevance: High

Feasibility: High

Related actions

Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites

Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria

Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon